Epigenetic Modification Mechanisms Involved in Inflammation and Fibrosis in Renal Pathology
Year: 2018
Type: review
Abstract: The growing incidence of obesity, hypertension, and diabetes, coupled with the aging of the population, is increasing the prevalence of renal diseases in our society. Chronic kidney disease (CKD) is characterized by persistent inflammation, fibrosis, and loss of renal function leading to end-stage renal disease. Nowadays, CKD treatment has limited effectiveness underscoring the importance of the development of innovative therapeutic options. Recent studies have identified how epigenetic modifications participate in the susceptibility to CKD and have explained how the environment interacts with the renal cell epigenome to contribute to renal damage. Epigenetic mechanisms regulate critical processes involved in gene regulation and downstream cellular responses. The most relevant epigenetic modifications that play a critical role in renal damage include DNA methylation, histone modifications, and changes in miRNA levels. Importantly, these epigenetic modifications are reversible and, therefore, a source of potential therapeutic targets. Here, we will explain how epigenetic mechanisms may regulate essential processes involved in renal pathology and highlight some possible epigenetic therapeutic strategies for CKD treatment.
Source: Mediators of Inflammation
DOI: 10.1155/2018/2931049
Institutions: Instituto de Salud Carlos III, Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Universidad Autónoma de Madrid, Austral University of Chile, Centro de Estudios Científicos, Hospital La Paz Institute for Health Research, Instituto de Investigación Biomédica de Lleida, Hospital Universitario Central de Asturias, Instituto de Investigación Sanitaria del Principado de Asturias
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,040
Awards: G1105841006, G1203152827, G1411212993, G1520406698, G1549641228, G1601999059, G1647210306, G1656282200, G1729306147, G1758420040, G1771215323, G2195660500, G2248545926, G2409041406, G2461751752, G2570692506, G2617777762, G2707686361, G3047972386, G3708003881, G3713805813, G3829256940, G3858600957, G3991268419, G4147198750, G422743462, G4248028612, G4330842474, Mecanismos moleculares implicados en la fibrosis asociada a la enfermedad renal crónica: búsqueda de nuevas estrategias terapéuticas, G4796369907, G4839351926, G5363784950, G5592101893, G6066374590, G6185492617, G6730178157, G6940920099, G7341080172, G7480015184, G748607132, G7682743076, Caracterización de un perfil lipidómico y lipídico de riesgo aterogénico y de morbimortalidad cardiovascular en la Enfermedad Renal Crónica (estadios 3 a 5) (estudio prospectivo NEFRONA), Papel de la alfa sinucleina en la enfermedad renal crónica. Implicaciones en la patologia de la fibrosis renal, Regulación epigenética de los procesos inflamatorios asociados al daño renal crónico. Identificación de nuevas dianas terapéuticas, G7764565850, G7812315499, G7837072621, G8359404183, G875433688, Daño cardiovascular asociado a la enfermedad renal crónica. Investigación de mecanismos moleculares y búsqueda de nuevas opciones terapéuticas
OpenAlex ID: W2903649030
